|
| |
PDQ Protease Assay™
| |
48
Ready-to-Use Vials |
| 0201 |
PDQ Protease Assay™ |
1 kit |
| |
96
Ready-to-Use Wells |
| 0203 |
PDQ MicroProtease Assay™ |
1 kit |
AthenaES's PDQ Protease Assay™:
Detects
protease activity in aqueous samples
Quantitative
or Qualitative Applications
No
Precipitation or Centrifugation needed
Simple and
easy to use
|
Storage |
Store at 4°C |
|
Stability at
4°C |
3 months |
The PDQ Protease Assay™ is a colorimetric assay used to detect
protease activity. The proprietary substrate is susceptible to a
wide range of proteases including serine, metallo, aspartate and
cysteine proteases such as collagenase, proteinase K, papain,
pepsin, bromelin, ficin, trypsin and chymotrypsin. This
substrate is a cross-linked matrix containing protein substrate
and a dye-protein conjugate. The matrix is supplied in plastic
vials or 96-well microplates, ready-to-use. Test samples
containing putative protease activity are aliquoted into the
vials which are then incubated at 37şC. Protease activity is
detected spectrophotometrically with increasing optical density
proportional to increasing enzyme activity. Each kit is supplied
with a trypsin control (BAEE equivalent units) for generating
standard curves.
PDQ Protease Assay™ Instructions
General Information
The PDQ (Protease Determine Quick test)™
Protease Assay is a colorimetric assay used to
detect protease activity. The proprietary
substrate is susceptible to a wide range of
proteases, e.g., collagenase, proteinase K,
papain, pepsin, bromelin, ficin, trypsin and
chymotrypsin. This substrate is a cross-linked
matrix containing protein and a dye-protein or
fluorescein-protein conjugate. The matrix is
supplied in 48 plastic vials or 96-well
microplates, ready-to-use. Test samples
containing putative protease activity are
aliquoted into the vials/wells which are then
incubated at 37°C. Protease activity is detected
spectrophotometrically or fluorometrically with
increasing optical density/fluorescence
proportional to increasing enzyme activity.
Kit Components
Standard Assays: 48 vials containing 200 µl of
pre-made matrix
Micro Assays: 96-wells containing 50 µl of
pre-made matrix
Trypsin (control)-0.5 ml of 0.7 mg/ml (1420 BAEE
units/mg) in reaction buffer (10mM Tris-Cl, pH
8.0).
Materials Not Provided but Required
0.2N NaOH
Spectrophotometer for reading absorbance at
450nm (standard PDQ)
Fluorometer for measuring485 nm excitation and
535 nm emission (fluorescent PDQ)
Instructions for Performing the PDQ Protease
Assay™
| 1. |
Allow the
vials/plates to come to room temperature
before running the assay. Pour off
storage solution. |
| 2. |
To
construct a standard curve, prepare a
ten-fold dilution series (20 - 0.032
mg/ml) of control protease. This control
solution should contain the protease for
which the test is being run (e.g., use
proteinase K in the control dilution
series if this is the protease being
tested for). If multiple proteases are
being tested for, then include
appropriate protease dilutions. |
| 3. |
Add 0.5mL
(for vials) 0.1 mL (for microplates) of
each control solution to duplicate
vials/plates. |
| 4. |
Prepare
test samples containing putative
protease activity in the same buffer as
control protease. Add 0.5/0.1 ml of the
test sample to duplicate vials/plates. |
| 5. |
Replace
snap caps onto vials or sealing tape
onto plates. |
| 6. |
Incubate
vials/plates at 37°C for 1 h. [1] ( a
shorter or longer incubation time may be
required. See Technical
Considerations.) |
| 7. |
Add 0.5mL
(for vials) 0.1mL (for microplates)l 0.2
N NaOH to each vial/well to stop the
reaction and to amplify the color. The
vials/plates contents should then be
gently swirled or tapped to mix. (Add
1.5ml 0.1N NaOH if assaying the contents
in standard cuvettes - for vials only). |
| 8. |
Transfer
the contents (being careful not to
disturb the semi-solid matrix) to
semi-micro or standard cuvettes (vial)
or to the wells of a microtiter plate
(plate). |
| 9. |
For
spectrophotometric assays, record
absorbance at 450 nm. For
fluorescence-based assay, record the
fluorescence for FITC settings (485 nm
excitation/ 535 nm emission). |
| 10. |
Average the
results from duplicate vials/wells and
use the control samples to generate a
standard curve, plotting concentration
(or amount) of control protease vs. A450
or fluorescence. Compare test sample
results against the standard curve
produced by the control protease
dilution series to obtain
semi-quantitative protease activity
data. |
Storage Conditions
Vials and microplates should be stored at 4°C
and have a 3 month shelf life.
Technical Considerations
Buffers that can be used to prepare test samples
may range in pH from 4 to 10.
The amount of time required for incubation can
be varied to optimize the assay. Up to 24 hr
incubations are possible, which will increase
the detection limits of the assay.
Alternatively, for applications with high
amounts of enzyme, 15 minutes may suffice. The
exact conditions should be determined
empirically.
As with any assay, it is necessary to run a
standard curve with control protease every time
the assay is performed with "unknown" protease
samples.
When using the vials, the stopped reaction
contents must be transferred to a cuvette to
measure the absorbance. The transfer of the
contents away from the PDQ matrix should be done
as soon as possible after the addition of
NaOH, since the NaOH will degrade the matrix
over time. However, the contents can be
left on the matrix for up to one hour
before transfer without compromising the
accuracy of the test.
Once the stopped reaction contents are
transferred away from the matrix, they can be
left for up to 24 hrs covered (to keep
out light) at room temperature before measuring
the absorbance without loss of signal.
|
A General Protease Substrate:
Gelatin-Albumin-Azoalbumin
G. P. Royer1
and Sheldon E. Broedel, Jr.2
Buford Biomedical, Frederick, MD1
Athena Environmental Sciences, Inc., Baltimore,
MD2
Abstract
We have developed a general protease substrate
consisting of cross-linked albumin, azoalbumin,
and gelatin. The substrate is susceptible to
proteolysis by a wide range of enzymes
including: collagenase, papain, bromelain,
trypsin, chymotrypsin, proteinase K, and
pronase. The assay can be run in screw-cap vials
or multi-well plates for high throughput
screens. Crude enzyme preparations which contain
particulate matter can be assayed using a
back-digestion technique for measurement of
residual solid. Nucleophiles, such as thiols, in
the assay buffers do not interfere. The limit of
detection of enzymes is less than 100 ng for
most enzymes tested. The very low labor input
and "hands-on" attention are decided advantages.
Introduction
Interest in proteases has increased with the
realization that they play key roles in
rheumatoid arthritis (1) and cancer metastasis
(2-3). Tumor progression depends on remodeling
of basement membrane prior to invasion and
angiogenesis. Some inhibitors of the proteases
which catalyze these processes have shown good
anti-tumor activity without the side effects of
cytotoxic drugs.
In addition to those investigators who target
proteases for research, biochemists are
generally concerned with protection of their
valuable proteins from unwanted degradation by
contaminating proteases. These workers need to
verify the presence or absence of proteases in
their preparations.
Modern methods have supplanted the classical
three-step assay-digestion, TCA precipitation,
and detection of TCA soluble peptides by UV
absorbance, the Folin-Ciocalteu reagent, or
other means. Two currently popular assays are
based on derivitized casein. In 1984, Twining
introduced a widely applicable and sensitive
assay based on fluorescein isocyanate-labelled
casein (4). This assay procedure suffers from
the cost of the substrate and labor intensity.
In 1992, Hatakeyama, et al., reported an assay
based on succinyl-casein and the TNBS reagent
for detection of liberated amino groups (5).
This assay can be run with the multi-well plate
reader. Disadvantages include failure to detect
collagenases, background due to reactive amines
or thiols, and interference from particulates in
the sample.
Our goal was to formulate a pipettable liquid
which could be conveniently dispensed into
microplates or vials. A number of cross-linking
reagents and numerous sets of reaction
conditions were tested before we settled on the
procedure described here which employs
formaldehyde, concentrated protein solutions and
sodium benzoate.
The substrate described here is a mixture of
gelatin and albumin cross-linked in the presence
of sulfaniloazo-albumin with formaldehyde at
slightly acidic pH. The translucent solid is
mechanically stable even at elevated
temperature. Twenty-four hour backgrounds
without protease are acceptably low, when the
assay mixture contains 0.1 % azide. Collagenase,
papain, bromelain, trypsin, chymotrypsin,
proteinase K, and pronase all exhibit good
activity against this protein matrix.
Materials and Methods
All chemicals were reagent grade or better.
Proteins and enzymes were supplied by Sigma as
follows: albumin (A2153), sulfanyloazo albumin
(A2382), gelatin (G2500), collagenase C0773,
papain (P4762), trypsin (T7409), chymotrypsin
(C7762), proteinase K (P5568), and pronase
(P0652); partially soluble enzyme preparations
pancreatin (1x, 4x, and 8x) and bromelain
(B22520), were used as supplied. Papaya latex
(P3375) was ground to a powder before use. Assay
buffers and storage solutions were prepared as
previously described (6).
Vial Assays. In a typical assay, 500 µl
of reaction buffer and 100 µl of enzyme solution
were added to vials containing the substrate
matrix, the vials sealed tightly, and incubated
at 37oC. The duration of the incubation was
varied from 5 min. to 24 hours. To stop the
reaction, 500 µl of 0.2N NaOH was added to each
vial. The absorbance at 450 nm of the aqueous
phase was measured spectrophotometrically.
For enzyme samples containing particulates, such
as the crude preparations studied here, a back
digestion technique was employed. After reacting
the crude preparation in the vial assay, the
assay mixture was poured off and the solid
substrate washed with water at the end of the
reaction period. The extent of hydrolysis was
established by digesting the remaining substrate
with an excess of enzyme such as proteinase K
(100ug). The amount of substrate digested by the
crude material was determined by the difference
between the no protease control (which
represents the total amount of substrate) and
the experimental (the residual amount of
substrate). This number divided by the control
value and multiplied by 100 equals the percent
maximal hydrolysis.
Multi-well Plate Assays. Alternate
columns of 96-well plates (Corning 25880-96)
were filled with substrate. The remaining empty
wells were used as working wells for absorbance
measurements. A typical assay consisted of 100
µl reaction buffer containing the respective
protease. After the elapsed reaction time at
37oC, 50 µl aliquots were transferred from the
assay wells to the respective adjacent working
wells. To each working well 50 µl of 0.1 N NaOH
was added and the absorbance was read at 450 nm
with a microplate reader (Molecular Devices,
UV-Max).
Results and Discussion
General characteristics of the protein-gel
matrix were assessed by examining matrix
deterioration under different environmental
conditions. The matrix was found to exhibit good
thermal stability, pH stability, resistance to
microbial attach, and susceptibility to a wide
variety of proteases including collagenase,
papain, bromelain, trypsin, chymotrypsin,
proteinase K, and pronase. This list encompasses
a diverse range with regard to active site
structure and mechanism.
Figure 1 shows time courses of the hydrolysis
catalyzed by collagenase, proteinase K, papain,
and chymotrypsin in the vial assay. All plots
were linear for the first two hours, and within
6 h, all of the substrate was consumed. The
rates are significantly higher for collagenase
(25µg) and proteinase K (25µg) than for papain
and chymotrypsin (50 µg of both in assay).
Reactions containing lesser amounts of proteases
(down to 50 ng) also showed linear rates but
required up to 20 h incubation. Similar results
were obtained with the microplate assay (data
not shown).
Figure 1.
Vial assay showing the time-course of papain,
chymotrypsin proteinase K, and collagenase. The
total volume was 600 ul and the temperature
370C. To produce these curves required 25 µg of
collagenase and proteinase K; papain and
chymotrypsin were present at 50µg/assay.
Figure 2.
Rate versus enzyme concentration for collagenase
for both the vial assay and the microplate
assay. The limit of detection was less than
30ng.
To assess microenvironmental effects, we examined the ph-dependencies
of several enzymes. Plots for the
chymotrypsin-catalyzed hydrolysis of
N-acetyl-tryptophan amide and the azo-albumin
gel versus pH show very similar profiles (Figure
3). These results suggest the absence of strong
microenvironmental effects coming to bear as a
result of diffusional limitations at the
interface between the solid substrate and the
bulk solution.
Figure 3.
pH-dependences of chymotrypsin with
N-acetyl-tryptophanamide and the azoalbumin
substrate. The similarity of the ph-profiles
would suggest the lack of any strong diffusional
limitations at the interface of the solid
substrate and the bulk solution.
One significant advantage of this assay system
is the ability to directly test enzyme samples
containing particulates. The enzyme along with
suspended material was incubated with the
substrate for the desired time. On completion of
the reaction the vial or microplate was washed
with water and the remaining substrate digested
with an excess of any protease. The difference
in absorbance of the control and experimental
sample represents the amount of digestion. Five
crude enzyme preparations which contained
particulates were tested with this back
digestion format. The assays were incubated for
one hour at 37oC with 5 mg of crude enzyme.
Following incubation, the vials were washed and
the residual substrate exhaustively digested
with 100 µg proteinase K. The results, shown in
Table 1, were that substrate digestion using
particulate containing solutions of bromelain
and pancreatin was measurable by this technique.
This demonstrates that protease activity in
crude preparations can be quantified with this
matrix assay.
| Percent Hydrolysis |
Enzyme |
| 0 |
None |
| 67 |
Bromelain |
| 31 |
Pancreatin 1x |
| 65 |
Pancreatin 2x |
| 76 |
Pancreatin 8x |
Table 1.Hydrolysis of azoalubumin gel catalyzed by crude enzyme
preparations containing particulate matter.
This assay may be useful as a high throughput
screening device for detection of protease
inhibitors such as matrix metalloproteinase
inhibitors. To illustrate, we used the
microplate format to study the inhibition of
trypsin by pancreatic trypsin inhibitor. Trypsin
(2 µg, 2.24 BAEE units) was mixed with different
amounts of bovine trypsin inhibitor and
incubated for 5 min. The residual trypsin
activity was measured in the microplate assay.
The results were consistent with known
stoichiometry (Figure 4).
Figure 4.Dose-dependent inhibition of
trypsin by bovine trypsin inhibitor. Inhibitor
at various concentrations, was incubated with 2
µg (2.24 BAEE units) of trypsin for 5 min.
Residual trypsin activity was measured in the
microplate protease assay as described in
Material and Methods for 20 h at 37°C.
The assay described here is a rapid, low-cost,
easy-to-use means of measuring protease
activity. Through different formats, the assay
can be applied to a rapid spot test (vial assay)
for routine protease test during the preparation
of biologicals, or when formatted in a
multi-well microplate, applicable to
high-throughput screens used to identify
pharmecutically activity compounds. To devise an
assay with a specific minimum cut-off would be
straightforward. The reaction time and thickness
of the substrate layer could be set to reflect
the desired sensitivity. A microplate well
exhibiting a "hit" or positive fraction would be
have solid substrate remaining above background
as judged by direct reading or by
back-digestion.
References
| 1. |
Davies, B.,
Broun, P. D., East, N. Crimmin, N. J.
and Balkwill, F. R.,(1993) Cancer Res.,
53, 2087-2091 |
| 2. |
Alvarez,
O.A., Carmichael, D. F., and DeClerck,
Y. A. (1990) J. Natl., Cancer Inst., 82,
589-595 |
| 3. |
Okada, Y.,
Nagase, H., and Harris, E. D. (1987), J.
Rheumatol., 14, 41-42 |
| 4. |
Twining, S.
S. (1984) Anal. Biochem., 143, 30-34. |
| 5. |
Hatakeyama,
T., Kohzaki, H. and Yamasaki, N. (1992)
Anal. Biochem. 48, 181-184 |
| 6. |
Various
authors (1970) in Methods in Enzymology
(Perleman, G.E. and Lorand, L., eds.)
Vol. 19, Academic Press, New York |
|
|
|